default author photo

Paul Baas

Netherlands Cancer Institute - Department of Thoracic Oncology

Postbus 90203

Amsterdam, 1006 BE

Netherlands

SCHOLARLY PAPERS

2

DOWNLOADS

192

TOTAL CITATIONS

5

Scholarly Papers (2)

1.

Radiotherapy Augments Pembrolizumab Responses and Outcomes in Metastatic Non-Small Cell Lung Cancer: Pooled Analysis of Two Randomized Trials

Number of pages: 33 Posted: 29 Dec 2019
Netherlands Cancer Institute - Department of Thoracic Oncology, Shandong University - Department of Radiation Oncology, Netherlands Cancer Institute - Department of Thoracic Oncology, Cleveland Clinic - Department of Quantitative Health Sciences, University of Texas at Houston - Department of Biostatistics, Netherlands Cancer Institute, Erasmus University Rotterdam (EUR) - Cancer Institute, VU University Medical Center, VU University Medical Center, Allegheny Health Network - Allegheny General Hospital, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Diagnostic Radiology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology and University of Texas at Houston - Department of Radiation Oncology
Downloads 112 (630,858)
Citation 5

Abstract:

Loading...

Radiotherapy, Anti-PD-1, Pembrolizumab, Pooled analysis, Metastatic Non-Small Cell Lung Cancer

2.

Switch Maintenance Gemcitabine after First Line Chemotherapy in Patients with Malignant Mesothelioma: A Randomized Open Label Phase II Trial (NVALT19)

Number of pages: 53 Posted: 31 Jan 2020
Netherlands Cancer Institute - Department of Thoracic Oncology, Netherlands Cancer Institute, Isala Hospital, Netherlands Cancer Institute - Department of Thoracic Oncology, Jeroen Bosch Hospital, Erasmus University Rotterdam (EUR) - Cancer Institute, Amphia Hospital, Deventer Hospital, Maxima Medical Centre, University of Groningen - Department of Pulmonary Diseases, Ziekenhuis Groep Twente, Netherlands Cancer Institute - Department of Thoracic Oncology, Zuyderland Medical Centre, University Medical Center Rotterdam - Erasmus MC Cancer Institute, Netherlands Cancer Institute - Department of Biometrics, Netherlands Cancer Institute, Erasmus University Rotterdam (EUR) - Cancer Institute, Netherlands Cancer Institute - Department of Thoracic Oncology and affiliation not provided to SSRN
Downloads 80 (803,225)

Abstract:

Loading...

Mesothelioma; gemcitabine; maintenance; randomised; NVALT; phase II